Can a voice-based program empower blind women through menopause?

NCT ID NCT07771946

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a specially designed audio-described education program can improve menopause knowledge and reduce symptom severity in visually impaired women. About 46 women aged 40-60 who are members of a blind association will be randomly assigned to receive the program or not. Researchers will measure changes in menopause knowledge and symptom scores using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Audio-described menopause education program
What this could lead to
If effective, this approach could offer a simple, accessible way to improve menopause knowledge and symptom management for visually impaired women.
What could go wrong
The trial is small (46 participants) and early, so results may not apply broadly. Education alone may not reduce physical symptoms, and outcomes depend on self-report.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Feb 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being a member of the Ankara Branch of the Altı Nokta Blind Association, * Being a woman with visual impairment (congenital or acquired), * Being female, * Being between 40 and 60 years of age, * Being able to speak Turkish, * Having no additional communication problems other than visual impairment, * Having experienced at least 12 months of amenorrhea (STRAW+1 criteria). Exclusion Criteria: * Refusal to participate in the study, * Previous participation in a structured menopause-related education program, * Use of pharmacological treatment for the management of menopausal symptoms, * Use of non-pharmacological methods for menopausal symptom management (e.g., yoga, aromatherapy, phytotherapy, etc.), * Surgical menopause, * Having additional disabilities other than visual impairment (hearing, intellectual, or physical disabilities). Withdrawal / Discontinuation Criteria * Initiation of any pharmacological or non-pharmacological intervention aimed at reducing menopausal symptoms during the study period, * Non-adherence to the study protocol, * Voluntary withdrawal from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopausal symptoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara University

    Ankara, Altindağ, 06250, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.